Director, MSAT Operations
ARTBIO
About this role
The Director, MSAT Operations at ARTBIO oversees the transfer and industrialization of radiopharmaceutical products and processes, ensuring facilities are compliant and ready for global expansion. They lead the development, validation, and scaling of manufacturing processes in a regulated environment and collaborate with internal teams and external partners to meet quality and safety standards.
Skills
Qualifications
About ARTBIO
artbio.comARTBIO is a biotechnology company developing a new class of alpha radioligand therapies to redefine cancer care. The company is building an ecosystem — from targeted radioligand drug candidates and radiochemistry to manufacturing, clinical infrastructure, and partnerships — to maximize the potential of these potent targeted therapies. ARTBIO aims to accelerate development and broaden patient access by combining precision targeting, specialized delivery, and collaborative clinical programs.
Recent company news
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Jul 29, 2025
Jonathan Freeman, Ph.D. Joins ARTBIO as Chief Business Officer
Jan 6, 2026
Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival
Jul 29, 2025
From CAR-T to RLT: Enhancing Precision Oncology with ARTBIO’s Radioligands
Aug 5, 2025
ARTBIO raises $132M to fuel alpha radiotherapy push with Pb212
Jul 29, 2025
About ARTBIO
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for ARTBIO.
Salary
$140k – $188k
per year